MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-PB-20-0015410
Alzan Pharmaceuticals Private Limited
Alzan Pharmaceuticals Private Limited - pharma in Barnala, Punjab, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹11.09 Cr
▲ 198% YoY
Net loss · FY 2024
₹26.54 Lakh
Net margin -2.4%
EBITDA · FY 2024
₹9.68 Lakh
EBITDA margin 0.9%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹25 Lakh
Issued & subscribed
Open charges
₹1.2 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Employees · EPFO
42
Provident fund records
About Alzan Pharmaceuticals Private Limited
Data last updated:
Alzan Pharmaceuticals Private Limited is a private limited company based in Barnala, Punjab, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24290PB2019PTC050320. Its GSTIN is 03AASCA9797R1ZD (Punjab).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors Shishu Pal and Nisha Rani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Dinesh Bansal S/O Ashok Kumar Nai Wala Road Near Puja Kanda, Barnala, Punjab, India – 148101.
As per the financials filed for FY 2024, the company reported a revenue of ₹11.09 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹26.54 Lakh (net margin -2.4%) and EBITDA of ₹9.68 Lakh (EBITDA margin 0.9%). Revenue has grown at a compounded annual rate (CAGR) of 258% over three years.
The company has about 42 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.2 Cr on record. Court records list 12 cases involving the company, including 1 filed by the company and 11 filed against it; 5 cases are pending.
Alzan Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-PB-20-0015410).
Company details
CIN U24290PB2019PTC050320
Registration Number 050320
Incorporation Date 25 November 2019
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification MSME
Udyam Registration UDYAM-PB-20-0015410
Recognitions & Rankings of Alzan Pharmaceuticals
Contact details
Alzan Pharmaceuticals Private Limited's registered office is in Barnala, Punjab. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O Dinesh Bansal S/O Ashok Kumar Nai Wala Road Near Puja Kanda, Barnala, Punjab, India – 148101
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Alzan Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Alzan Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Alzan Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Alzan Pharmaceuticals Private Limited, buy the company report.
Financials of Alzan Pharmaceuticals Private Limited
FY 2025 filings availableAlzan Pharmaceuticals Private Limited reported revenue of ₹11.09 Cr (up 198% YoY) for FY 2024.
Revenue · FY 2024
₹11.09 Cr ▲ 198%
Net loss · FY 2024
₹26.54 Lakh margin -2.4%
EBITDA · FY 2024
₹9.68 Lakh margin 0.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 198%
3 years · compounded
▲ 258%
EBITDA CAGR growth
1 year
▲ 120%
3 years · compounded
▲ 59%
Revenue has grown at a compounded annual rate (CAGR) of 258% over three years, including 198% growth in the latest year. EBITDA rose 120% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.68 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹26.54 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | ||||
| Net Profit Margin | -2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alzan Pharmaceuticals Private Limited, buy the company report.
Board of directors of Alzan Pharmaceuticals Private Limited
Alzan Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shishu Pal | Additional Director | 22 Jun 2020 | 6 Years 4 Months | Current |
| Nisha Rani | Additional Director | 22 Jun 2020 | 6 Years 4 Months | Current |
Peer comparison
Alzan Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tomoz Spices and Products Private Limited | ₹11.14 Cr (FY 2022) | 467.0% | Thiruvaniyoor, Kerala, India | |||
| Pranada Biopharma Private Limited | ₹11.13 Cr (FY 2024) | -3.0% | Mumbai, Maharashtra, India | |||
| Adit Innovation Private Limited | ₹11.1 Cr (FY 2024) | 9.0% | Ahmedabad, Gujarat, India | |||
| Alzan Pharmaceuticals Private Limitedthis company | ₹11.09 Cr (FY 2024) | -₹26.54 Lakh | -2.4% | 198.0% | 42 | Barnala, Punjab, India |
| Shinemax Pharma (India) Private Limited | ₹11.09 Cr (FY 2024) | 39.0% | Mysore, Karnataka, India | |||
| CL Laboratories Private Limited | ₹11.08 Cr (FY 2025) | 4.0% | Indore, Madhya Pradesh, India | |||
| Optish Life Science Private Limited | ₹11.04 Cr (FY 2025) | 1.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Alzan Pharmaceuticals Private Limited, buy the company report.
Auditor
Alzan Pharmaceuticals Private Limited is audited by APMG & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| APMG & CO | FY 2023 | 021716 |
Shareholding
The shareholding of Alzan Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Alzan Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.2 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Aug 2021 | 100483478 | Indian Bank | ₹1.2 Cr | Open |
Total charge records: 1 View all charges
Legal cases
Alzan Pharmaceuticals Private Limited has 12 court cases on record: 1 filed by Alzan Pharmaceuticals, 11 filed against it. 5 cases are pending and 7 are disposed.
Total cases
12
Filed by the company
1
Filed against the company
11
Pending
5
Disposed
7
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 9 | 5 |
| High courts | 3 | 2 | 0 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Commercial suit | Filed against the company by M/S Samchem India Private Limited | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed against the company by Welcome Pharmalife Pvt Ltd Through Its Business Marketing Development Mr Rajen Gunvantrai Sangani | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by Tiwari Pharma Pvt Ltd | Disposed |
| District court, SAS Nagar, Punjab | Execution petition | Filed against the company by M/S Bansal Enterprises | Pending |
| District court, Thane, Maharashtra | Court case (Sum.Civ.Suit) | Filed against the company by Maruti Chemi Pharma | Pending |
To see the full case history of Alzan Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alzan Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Alzan Pharmaceuticals Private Limited has a workforce of 42 employees on its EPFO records as of Apr 10, 2024, across 1 active EPFO establishment.
Employee count
42
Active EPFO establishments
1
Employee growth
133.33%
GST
Alzan Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AASCA9797R1ZD | Punjab | Active | 16 Jan 2020 |
To see the full GST registrations and return filing status of Alzan Pharmaceuticals Private Limited, buy the company report.
Recent activity
Alzan Pharmaceuticals Private Limited has 6 board changes on record since 2020: 2 appointments and 4 cessations. The latest: Vidit Aggarwal ceased to be Additional Director on 16 Jul 2022.
AGM
Alzan Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Alzan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Ceased
Vidit Aggarwal ceased to be Additional Director.
Ceased
Rajbir Singh ceased to be Additional Director.
Charges
A charge with Indian Bank amounted to Rs. 120.00 Lakh with Charge ID 100483478 was registered on 25 Aug 2021.
Ceased
Ashok Kumar ceased to be Director.
Appointed
Nisha Rani was appointed as Additional Director.
Appointed
Shishu Pal was appointed as Additional Director.
Ceased
Dinesh Bansal ceased to be Director.
Incorporation
25 Nov 2019
Alzan Pharmaceuticals Private Limited was registered on 25 Nov 2019 with Roc Chandigarh & aged 6 years 11 months as per MCA records.
Frequently asked questions
Alzan Pharmaceuticals is an active private limited company based in Barnala, Punjab, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 November 2019 (7+ years old) and is registered under CIN U24290PB2019PTC050320.
Alzan Pharmaceuticals has 2 current directors:
- Shishu Pal - Additional Director
- Nisha Rani - Additional Director
The latest financial statements of Alzan Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Alzan Pharmaceuticals is 03AASCA9797R1ZD, registered in Punjab.
The CIN (Corporate Identification Number) of Alzan Pharmaceuticals is U24290PB2019PTC050320. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alzan Pharmaceuticals has 12 court cases on record: 1 filed by the company and 11 filed against it. 5 are pending. Most are in the district courts.
Alzan Pharmaceuticals was incorporated on 25 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Alzan Pharmaceuticals by revenue are Tomoz Spices and Products Private Limited, Pranada Biopharma Private Limited, Adit Innovation Private Limited, Shinemax Pharma (India) Private Limited, CL Laboratories Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Vidit Aggarwal ceased to be Additional Director on 16 Jul 2022. Rajbir Singh ceased to be Additional Director on 11 Oct 2021. Ashok Kumar ceased to be Director on 24 Jun 2020. Alzan Pharmaceuticals has 6 board changes on record in total.
Yes, Alzan Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-PB-20-0015410).
The registered office of Alzan Pharmaceuticals is at CO Dinesh Bansal SO Ashok Kumar Nai Wala Road Near Puja Kanda, Barnala, Punjab, India – 148101.